Fexuprazan is a potassium‐competitive acid pump antagonist, which reversibly blocks the proton pump that secretes gastric ...

The thoughtless behavior after eating has a great effect on the digestive system.Bad postprandial habits can cause problems ...

Medically reviewed by Qin Rao, MD Regurgitation happens when stomach content moves back up into your throat or mouth.GER and GERD are the most common causes of regurgitation.Prevent regurgitation by ...

A genetically susceptible individual is exposed to a food antigen, which activates the immune system and triggers differentiation into Th2 cells that release cytokines with eosinophil properties.

From November 2004 to March 2005, 263 consecutive patients who were referred for diagnostic investigation to the Gastroenterology Clinic of Asan Medical Center, presenting dyspepsia without heartburn ...

Objective To examine the association between dietary glycemic index (GI), glycemic load (GL), total carbohydrate, sugars, starch, and fiber intakes and the risk of reflux esophagitis, Barrett's ...

However, a newly published meta-analysis in gastroenterology raises a crucial clinical dilemma: Could the treatment itself, intended to heal, paradoxically increase the risk of reflux oesophagitis (RE ...

The median age of the 150 children (91 boys, 56 girls) studied was 8.2 years (IQR 7); 163 parents were approached (response rate of 92%). Spirometry was normal in all children who could perform ...

DALLAS – Nov. 19, 2009 – Contrary to current thinking, a condition called gastroesophageal reflux disease (GERD) might not develop as a direct result of acidic digestive juices burning the esophagus, ...

Peptic stricture was traditionally looked upon as an irreversible end stage of acid–peptic damage. Patients with peptic stricture are characterized by advanced age, male gender, and vastly abnormal ...

The long-term safety and efficacy of medical therapy compared with antireflux surgery for the treatment of patients with chronic GERD is not clear. This randomized, multicenter prospective study ...

Last month, the Food and Drug Administration (FDA) approved Voquenza Dual (vonoprazan fumarate + amoxicillin) and Triple Paks (vonoprazan fumarate + amoxicillin + clarithromycin) for the treatment of ...